HAOHAI BIOTEC (06826) spent HKD 2.1994 million to repurchase 78,900 shares on November 27th.
Hao Hai Biological Technology (06826) announced on November 27, 2025 that the company repurchased 78,900 shares at a cost of 2.1994 million Hong Kong dollars, at a repurchase price of HKD 27.64-27.98 per share.
HAOHAI BIOTEC (06826) announced that on November 27, 2025, the company spent 2.1994 million Hong Kong dollars to repurchase 78,900 shares at a repurchase price of 27.64-27.98 Hong Kong dollars per share.
Related Articles

Innovation New Material Technology(600361.SH): Hualian Group plans to reduce its shareholding by no more than 1%

GOLDWAY EDU (08160) issues profit warning, expecting mid-term net loss attributable to shareholders to increase to approximately HK$7.6 million.

ANTON OILFIELD (03337) cancels 49.176 million repurchased shares.
Innovation New Material Technology(600361.SH): Hualian Group plans to reduce its shareholding by no more than 1%

GOLDWAY EDU (08160) issues profit warning, expecting mid-term net loss attributable to shareholders to increase to approximately HK$7.6 million.

ANTON OILFIELD (03337) cancels 49.176 million repurchased shares.

RECOMMEND

Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025

Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025

Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025


